Table 2.
Progression and regression of AKI during the first 48 h of ICU admission and median admission NGAL plasma levels
| Maximum AKI stage development during first 48 h |
|||||
|---|---|---|---|---|---|
| Number of patients, n | |||||
| NGAL at admission (ng/mL), median (IQR) | |||||
| AKI stage at admission | AKI 0 | AKI 1 | AKI 2 | AKI 3 | |
| AKI 0 | 211 | 53 | 29 | 4 | |
| 106 | 121 | 155 | 367 | ||
| (76–150) | (71–169) | (109–190) | (120–800) | ||
| AKI 1 | 10 | 7 | 7 | 5 | |
| 309 | 254 | 348 | 437 | ||
| (174–570) | (174–275) | (154–422) | (223–637) | ||
| AKI 2 | 1 | 6 | 10 | 2 | |
| 2076 | 365 | 376 | 3230 | ||
| (131–647) | (278–573) | ||||
| AKI 3 | 1 | 0 | 3 | 12 | |
| 589 | 1013 | 601 | |||
| (370–1499) | |||||
Green squares are patients with improvement of AKI levels during the first 48 h. Yellow squares are patients with no change in AKI levels during the first 48 h. Red squares are patients with deterioration in AKI levels during the first 48 h.